Bioprocess Machine Digital Controller for Automated Fluid Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The setup and operation of biotechnological fluid treatment installations are cumbersome due to the need for extensive cleaning and maintenance of reusable components, and existing disposable solutions lack flexibility in automating treatment processes.

Innovation Solution

A system comprising a bioprocess machine with a biotechnological fluid treater and a digital controller, along with a machine helper, enables machine-to-machine communication and pairing over a network, allowing for automated reconfiguration and enhanced flexibility by providing and consuming capabilities for modifying physico-chemical or biological properties of the fluid, even during batch processes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If reusable components (stainless steel pipes, tanks, filter housings) are used in biotechnological fluid treatment installations, then the installation can be used multiple times, but extensive cleaning and maintenance operations are required before and after each treatment

Engineering Contradiction:
Improvereusability of installationVSAvoidcleaning and maintenance operations
Core Design Contradiction:
ProductivityVSEase of operation

Solution Approach 1:

The patent applies disposable single-use components (bags, circuits, filter elements) that are discarded after one treatment cycle, eliminating the need for cleaning and maintenance operations while maintaining productivity. These disposable components are replaced rather than cleaned, solving the contradiction between reusability and ease of operation.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Ease of operation

If disposable components are used to avoid cleaning operations, then ease of operation is improved, but flexibility in automating treatment processes is reduced

Engineering Contradiction:
Improveavoidance of cleaning operationsVSAvoidflexibility in automating treatment processes
Core Design Contradiction:
Ease of operationVSAdaptability or versatility

Solution Approach 1:

The patent implements a universal digital controller that can manage multiple disposable components and treatment processes through standardized interfaces. The controller provides multi-functional capabilities including process control, monitoring, and automation across different treatment types, restoring flexibility and adaptability while maintaining the ease of operation provided by disposable components.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system enables automated treatment processes where the digital controller automatically manages the disposable components without requiring manual intervention for setup or operation. The automation capability allows the system to configure and execute treatments autonomously, compensating for the reduced adaptability that might otherwise result from using disposable components.

Inventive Principle:
Principle #25Self-service

3Extent of automation

If machine helper is added to enhance automation capability, then extent of automation is improved, but device complexity increases due to additional communication and pairing components

Engineering Contradiction:
Improveautomation capabilityVSAvoidcommunication and pairing components
Core Design Contradiction:
Extent of automationVSDevice complexity

Solution Approach 1:

The patent introduces a machine helper as an intermediary device that facilitates communication between the digital controller and external systems or additional components. The helper manages complex communication protocols and pairing operations, shielding the main controller from complexity while enabling enhanced automation capabilities through standardized intermediary interfaces.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS20230340395A1System for treating a biotechnological fluid
Publication Date: 2023.10.26 MERCK PATENT GMBH
  • US20230340395A1 patent drawing
  • US20230340395A1 patent drawing
  • US20230340395A1 patent drawing

AI summary

The present application relates to biotechnological fluid treating, such as biopharmaceutical liquids in order to obtain products such as monoclonal antibodies, vaccines or recombinant proteins, and particularly to a system for treating a biotechnical fluid, having a bioprocess machine and at least one bioprocess machine helper, configured to connect to each other and each comprising a controller, in turn comprising a machine-to-machine communication tool configured for connecting to a network